The causes of hypercalcemia in Okinawan patients: An international comparison

Internal Medicine

Volumn 46, Issue 1, 2007, Pages 23-28

  Tokuda, Yasuharu ^a   Maezato, Kyouko ^b   Stein, Gerald H ^c,d  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

Calcium; Differential diagnosis; Hypercalcemia of malignancy; Hyperparathyroidism; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AGED; BREAST CARCINOMA; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; EASTERN HEMISPHERE; FEMALE; HUMAN; HYPERCALCEMIA; JAPAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; REVIEW; T CELL LEUKEMIA; TEACHING HOSPITAL; WESTERN HEMISPHERE;

ADULT; AGED; AGED, 80 AND OVER; FAR EAST; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; WESTERN WORLD;

EID: 33846048364     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6052     Document Type: Review

References (42)

1. Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 352: 306-311, 1998.
2. Deftos LJ. Hypercalcemia in malignant and inflammatory diseases. Endocrinol Metab Clin North Am 31: 141-158, 2002.
3. Fisken RA, Heath DA, Bold AM. Hypercalcaemia - a hospital survey. Q J Med 49: 405-418, 1980.
4. Fisken RA, Heath DA, Somers S, Bold AM. Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet 1: 202-207, 1981.
5. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-Based Medicine Working Group. JAMA 281: 1214-1219, 1999.
6. Rizzoli R, Thiebaud D, Bundred N, et al. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab 84: 3545-355, 1999.
7. Gorog RH, Hakim MK, Thompson NW, Rigg GA, McCann DS. Radioimmunoassay of serum parathyrin: comparison of five commercial kits. Clin Chem 28: 87-91, 1982.
8. Burtis WJ, Brady TG, Orloff JJ, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322: 1106-1112, 1990.
9. Shek CC, Natkunam A, Tsang V, Cockram CS, Swaminathan R. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong. Q J Med 77: 1277-1285, 1990.
10. Lee JK, Chuang MJ, Lu CC, et al. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. J Endocrinol Invest 20: 404-409, 1997.
11. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism 31: 1247-1277, 1982.
12. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112: 499-504, 1990.
13. Nussbaum SR, Younger J, Vandepol CJ, et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60, and 90-mg dosages. Am J Med 95: 297-304, 1993.
14. Barri YM, Knochel JP. Hypercalcemia and electrolyte disturbances in malignancy. Hematol Oncol Clin North Am 10: 775-790, 1996.
15. Fukumoto S, Matsumoto T, Ikeda K, et al. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med 148: 921-925, 1988.
16. Prager D, Rosenblatt JD, Ejima E. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leuk Lymphoma 14: 395-400, 1994.
17. Blomqvist CP. Malignant hypercalcemia - a hospital survey. Acta Med Scand 220: 455-463, 1986.
18. Ling PJ, A'Hern RP, Hardy JR. Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). Br J Cancer 72: 206-209, 1995.
19. Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med 103: 134-145, 1997.
20. Motokura T, Fukumoto S, Matsumoto T, et al. Parathyroid hormone-related protein in adult T-cell leukemia-lymphoma. Ann Intern Med 111: 484-488, 1989.
21. Shih LY, Kuo TT, Dunn P, Liaw SJ. Human T-celt lymphotropic virus type I associated adult T-cell leukaemia/lymphoma in Taiwan Chinese. Br J Haematol 79: 156-161, 1991.
22. Zhuo J, Yang T, Zeng Y, Lu L. Epidemiology of anti-human T-cell leukemia virus type I antibody and characteristics of adult T-cell leukemia in China. Chin Med J (Engl) 108: 902-906, 1995.
23. Chan WP, Liang R. Sequence analysis of HTLV-1 provirus associated with adult T-cell leukemia/lymphoma in Hong Kong. Am J Hematol 51: 94-95, 1996.
24. Nakada K, Yamaguchi K, Furugen S, et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer 40: 145-148, 1987.
25. Kobayashi T, Baba M, Tanaka N, et al. [Analysis of 30 patients with hypercalcemia]. Nippon Geka Gakkai Zasshi 94: 1125-1130, 1993.
26. Burt ME, Brennan MF. Incidence of hypercalcemia and malignant neoplasm. Arch Surg 115: 704-707, 1980.
27. Delmez JA, Kelber J, Norwood KY, Giles KS, Slatopolsky E. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients. Clin Nephrol 54: 301-308, 2000.
28. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1: 1317-1320, 1980.
29. Jorde R, Bonaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 53: 1164-1169, 2000.
30. Pu SJ, Huang MJ, Huang BY, Huang HS, Wang PW. [Hypercalcemia - clinical analysis of 116 hospital patients]. Taiwan Yi Xue Hui Za Zhi 85: 589-595, 1986 (in Chinese).
31. Asada K, Chida K. [Prognosis and prognostic factors of sarcoidosis in Japan]. Nippon Rinsho 60: 1839-1844, 2002 (in Japanese).
32. Ko YC, Lee CT, Cheng YF, et al. Hypercalcaemia and haemophagocytic syndrome: rare concurrent presentations of disseminated tuberculosis in a dialysis patient. Int J Clin Pract 58: 723-725, 2004.
33. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 6: 442-447, 2000.
34. Lufkin EG, Kao PC, Heath H 3rd. Parathyroid hormone radioimmunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy. Ann Intern Med 106: 559-560, 1987.
35. Rankin W, Grill V, Martin TJ. Parathyroid hormone-related protein and hypercalcemia. Cancer 80(8 Suppl): 1564-1571, 1997.
36. Rizzoli R, Vadas L, Bonjour JP. Determination of circulating parathyroid hormone levels and differential diagnosis of hypercalcemia. Nucl Med Biol 21: 337-347, 1994.
37. Strodel WE, Thompson NW, Eckhauser FE, Knol JA. Malignancy and concomitant primary hyperparathyroidism. J Surg Oncol 37: 10-12, 1988.
38. Fierabracci P, Pinchera A, Miccoli P, et al. Increased prevalence of primary hyperparathyroidism in treated breast cancer. J Endocrinol Invest 24: 315-320, 2001.
39. Lafferty FW. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med 141: 1761-1766, 1981.
40. Wong ET, Freier EF. The differential diagnosis of hypercalcemia. An algorithm for more effective use of laboratory tests. JAMA 247: 75-80, 1982.
41. Boyd JC, Ladenson JH. Value of laboratory tests in the differential diagnosis of hypercalcemia. Am J Med 77: 863-872, 1984.
42. Vargas SJ, Diez-Morales LF, Jones TG, Froesch TA, Hurley MM, Raisz LG. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia: a reanalysis. Am J Med Sci 294: 415-418, 1987.